As per the research report, the size of the Middle East and Africa Endoscope Reprocessing Market is valued at USD 0.10 billion in 2022 and estimated to grow at a CAGR of 8.59%, reaching USD 0.15 billion by 2027 during the forecast period 2022 to 2027.
Increasing prevalence for endoscopic procedures, a high risk of endoscope-associated infections, a growing senior population and the resulting increase in endoscopic procedures, and a growing emphasis on improving reprocessing guidelines by healthcare facilities will drive the MEA market during the forecast period.
In addition, increasing demand for surgical treatments that result in faster recovery, fewer post-surgery infections, less scarring, minor discomfort, better bleeding control, & higher precision is projected to drive up demand for endoscope reprocessing market. The need for the market to diagnose and treat cancer and GI problems is being driven by the rising pediatric population, which is particularly vulnerable to targeted diseases.
Endoscopy devices are also utilized to explore atypical symptoms such as dysphagia, diarrhea, weight loss, heartburn, and stool blood, which is driving the development of endoscope reprocessing to reduce infection risk. Furthermore, health organizations are implementing facility-level training programs to help healthcare facilities achieve consistent, high-quality endoscope reprocessing. Growing focus on enhancing reprocessing criteria, is expected to propel the market forward.
The rising prevalence of endoscopy-related infections increased hospital investments in endoscopy tools. In addition, the rising number of disorders requiring endoscopic operations are all driving the endoscope reprocessing market forward. As a result, endoscopic devices are being used more frequently in illness detection and therapy. In addition, the rising prevalence of disorders detectable by endoscopy has boosted the demand for these devices.
Concerns about recycled devices' safety may further impede the expansion of the MEA endoscope reprocessing market. The lack of a regulatory framework in the Middle East and Africa inhibits the market's growth. These countries frequently suffer from a lack of political attention for concerns with medical product reuse. Saudi Arabia has been noted to be in the process of developing regulatory legislation, although this regulation forbids the reuse of products.
As a result, the above factors limit the region's reprocessing market. Another impediment to this business is people's preconceived ideas about device quality.
This research report on the Middle East & Africa Endoscope Reprocessing Market has been segmented and sub-segmented into the following categories.
By End User:
Geographically, the Middle East & Africa Endoscope Reprocessing Market is likely to dominate the market share globally because reprocessing reuse is frequent, especially when it comes to cardiac catheters during the forecast period.
The UAE endoscope reprocessing market is projected to witness the highest CAGR forecast period. Despite the lack of evidence of legislative frameworks, there is a growing demand for class I devices in the GCC countries, and corporations are progressively migrating toward the usage of reprocessed instruments.
The Saudi Arabia endoscope reprocessing market is expected to grow significantly owing to an increase in their product range; major market participants are working on getting new products approved.
The South African endoscope reprocessing market is predicted to develop due to the increased usage of endoscope reprocessors in hospitals for infection prevention and control and the emergence of automated endoscope reprocessors (AER) in healthcare settings. By standardizing numerous critical reprocessing stages and lowering the risk of human error, AERs can improve the reliability and consistency of endoscope reprocessing. In addition, personnel exposure to hazardous chemical germicides is reduced when AERs are used, lowering the health concerns associated with endoscope reprocessing.
KEY MARKET PLAYERS
The leading companies leading in the MEA Endoscope Reprocessing Market profiled in the report are Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), ENDO-TECHNIK (Germany), BES Decon (UK), Steelco (Italy), ARC Healthcare Solutions (Canada), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Getinge (Sweden), and Metrex Research (US) among others.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org